News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,880 Results
Type
Article (87816)
Company Profile (824)
Press Release (779226)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233189)
Career Advice (4144)
Deals (39847)
Drug Delivery (145)
Drug Development (91380)
Employer Resources (203)
FDA (18369)
Job Trends (17415)
News (397766)
Policy (39953)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (35)
Allergies (138)
Alliances (56981)
ALS (175)
Alzheimer's disease (1772)
Antibody-drug conjugate (ADC) (317)
Approvals (18521)
Artificial intelligence (586)
Autoimmune disease (142)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (197)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (62)
Breast cancer (633)
Cancer (4793)
Cardiovascular disease (421)
Career advice (3566)
Career pathing (40)
CAR-T (295)
CDC (59)
Celiac Disease (1)
Cell therapy (796)
Cervical cancer (37)
Clinical research (76707)
Collaboration (1643)
Company closure (5)
Compensation (1098)
Complete response letters (67)
COVID-19 (2983)
CRISPR (94)
C-suite (763)
Cystic fibrosis (148)
Data (5970)
Decentralized trials (2)
Denatured (69)
Depression (136)
Diabetes (506)
Diagnostics (7184)
Digital health (42)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (284)
Drug pricing (210)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (99920)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134686)
Executive appointments (1012)
FDA (21343)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1462)
Gene editing (205)
Generative AI (60)
Gene therapy (639)
GLP-1 (1099)
Government (5429)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (56)
Huntington's disease (45)
IgA nephropathy (82)
Immunology and inflammation (280)
Immuno-oncology (45)
Indications (79)
Infectious disease (3259)
Inflammatory bowel disease (199)
Inflation Reduction Act (16)
Influenza (116)
Intellectual property (228)
Interviews (816)
IPO (17947)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10155)
Liver cancer (96)
Longevity (14)
Lung cancer (659)
Lymphoma (368)
Machine learning (40)
Management (66)
Manufacturing (770)
MASH (169)
Medical device (14984)
Medtech (15027)
Mergers & acquisitions (22904)
Metabolic disorders (1321)
Multiple sclerosis (153)
NASH (23)
Neurodegenerative disease (328)
Neuropsychiatric disorders (88)
Neuroscience (3003)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (634)
Opinion (328)
Ovarian cancer (157)
Pain (194)
Pancreatic cancer (213)
Parkinson's disease (280)
Partnered (37)
Patents (481)
Patient recruitment (432)
Peanut (59)
People (66696)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23687)
Phase II (33283)
Phase III (25107)
Pipeline (4194)
Policy (324)
Postmarket research (3554)
Preclinical (10672)
Press Release (72)
Prostate cancer (233)
Psychedelics (53)
Radiopharmaceuticals (294)
Rare diseases (830)
Real estate (7437)
Recruiting (80)
Regulatory (28727)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (152)
Series A (244)
Series B (180)
Service/supplier (30)
Sickle cell disease (102)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4328)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (117)
Vaccines (1116)
Venture capital (83)
Weight loss (442)
Women's health (79)
Worklife (21)
Date
Today (151)
Last 7 days (242)
Last 30 days (1789)
Last 365 days (33308)
2026 (189)
2025 (33230)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (332)
Arkansas (14)
Asia (51416)
Australia (9025)
California (10990)
Canada (3214)
China (1097)
Colorado (462)
Connecticut (485)
Delaware (334)
Europe (118100)
Florida (1613)
Georgia (355)
Hawaii (3)
Idaho (68)
Illinois (912)
India (63)
Indiana (527)
Iowa (22)
Japan (402)
Kansas (131)
Kentucky (41)
Louisiana (29)
Maine (81)
Maryland (1408)
Massachusetts (8144)
Michigan (346)
Minnesota (637)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (81)
New Jersey (2996)
New Mexico (32)
New York (2938)
North Carolina (1548)
North Dakota (10)
Northern California (5201)
Ohio (334)
Oklahoma (22)
Oregon (52)
Pennsylvania (2220)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4223)
Tennessee (169)
Texas (1737)
United States (39955)
Utah (330)
Vermont (1)
Virginia (277)
Washington D.C. (85)
Washington State (929)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
There are 867,880 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight Loss
Lilly’s Path to $94B in Revenue Rests on Oral Obesity Market and Other 2026 Milestones
The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with their new obesity pills this year.
January 5, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Moss Genomics Reports Bitcoin Cash (BCH) Mining Activity
January 5, 2026
·
3 min read
Press Releases
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
January 5, 2026
·
10 min read
Press Releases
OS Therapies Provides First Half 2026 Corporate Outlook
January 5, 2026
·
8 min read
Press Releases
Nanjing Delova Announces Statistically Significant and Clinically Meaningful Results From Two Phase 3 Trials of QP-6211 for the Treatment of Postoperative Pain
January 5, 2026
·
1 min read
Obesity
Novo Unveils Oral Wegovy in the US, With Out-of-Pocket Prices at $149 Per Month
After getting the crucial first-mover advantage with an FDA approval for a weight loss pill, Novo Nordisk looks to win the market before rival Lilly can arrive with its own oral option for obesity.
January 5, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Neogen® Announces Two Senior Leadership Appointments
January 5, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
January 5, 2026
·
5 min read
Press Releases
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
January 5, 2026
·
6 min read
1 of 86,788
Next
